BIOSPECIFICS TECHNOLOGIES
BioSpecifics Technologies Corp., a biopharmaceutical company, is engaged in the development of an injectable collagenase for various indications primarily in the United States. It provides injectable collagenase under the XIAFLEX name for the treatment of Dupuytren’s contracture and Peyronie’s disease. The company also develops XIAFLEX injectable collagenase for frozen shoulder, cellulite, human lipoma, canine lipoma, and uterine fibroid indications, as well as for keloids, hypertrophic scars, scarred tendons, glaucoma, herniated intervertebral discs, and as an adjunct to vitrectomy indications. It has a development and license agreement with Auxilium Pharmaceuticals, Inc. The company was founded in 1957 and is headquartered in Lynbrook, New York.
BIOSPECIFICS TECHNOLOGIES
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
1957-01-01
Address:
Lynbrook, New York, United States
Country:
United States
Website Url:
http://www.biospecifics.com
Total Employee:
1+
Status:
Active
Contact:
516 5937039
Technology used in webpage:
SPF SSL By Default Content Delivery Network Google Universal Analytics Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Cloudflare Cloudflare Hosting Cloudflare SSL
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Employees Featured
Stock Details
Official Site Inspections
http://www.biospecifics.com
- Host name: 69.172.200.252
- IP address: 69.172.200.252
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
